AstraZeneca (LON:AZN) Insider Sells £40,083.12 in Stock

AstraZeneca PLC (LON:AZN) insider Nazneen Rahman sold 297 shares of AstraZeneca stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of £134.96, for a total value of £40,083.12.

AstraZeneca Price Performance

Shares of LON:AZN opened at £135.94 on Monday. The company has a market cap of £210.75 billion, a P/E ratio of 22.58, a P/E/G ratio of 0.86 and a beta of 0.17. The business has a fifty day simple moving average of £132.20 and a 200-day simple moving average of £119.23. AstraZeneca PLC has a 52 week low of GBX 9,573.51 and a 52 week high of £142.06. The company has a quick ratio of 0.59, a current ratio of 0.93 and a debt-to-equity ratio of 73.83.

Wall Street Analyst Weigh In

A number of analysts have recently commented on AZN shares. Shore Capital restated a “buy” rating and set a £145 price objective on shares of AstraZeneca in a report on Thursday, November 6th. Jefferies Financial Group reissued a “buy” rating and set a £150 price target on shares of AstraZeneca in a research report on Monday, November 10th. Berenberg Bank raised their price objective on AstraZeneca from £142 to £145 and gave the stock a “buy” rating in a report on Tuesday, October 21st. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a £140 price objective on shares of AstraZeneca in a research note on Thursday, December 4th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of £138.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.